The $2.2 Billion Backlog That Can't Calm Rocket Lab's Stock

Rocket Lab shares sink 36% in a month, RSI 30.2 oversold, yet analysts project 73% upside. Piper Sandler neutral, Iridium acquisition fuels dilution fears despite 63.5% revenue growth.

The gap between market sentiment and analyst expectations for Rocket Lab has rarely been this extreme. With the stock down 36.85% over the past month and an RSI of 30.2 signaling deeply oversold territory, traders are bracing for more pain — while Wall Street sees a roughly 73% upside from current levels. The disconnect stems from two powerful forces: a broad sell-off in space stocks and a controversial $8 billion acquisition that has traders nervous about dilution.

Piper Sandler's inaugural "Final Frontier" sector report delivered the initial shock. The bank assigned a Neutral rating to both Rocket Lab and SpaceX, arguing that vertically integrated launch providers carry a more complex risk-reward profile than optimists have priced in. The single buy rating in the entire report went to another company — a subtle snub that sent Rocket Lab's shares plunging 11.6% in a single session. That one call effectively erased months of gains, leaving the stock at roughly €59.30 by week's end. The annualized volatility of 96% underscores just how jittery the trading has become.

The sector-wide rout compounded the damage. An aborted Starship flight test and rising anxiety over the profitability of massive AI and infrastructure investments wiped an estimated $600 billion in market value from space-related equities in roughly a month. SpaceX fell below its IPO price, AST SpaceMobile lost about a third of its value, and Rocket Lab was swept along, tumbling 55.68% from its late-May 2026 record of €133.80. The stock now sits more than €60 below its 50-day moving average of €93.64 — a technical indicator that typically flags severe short-term dislocation.

Investors have also fixated on the Iridium Communications acquisition announced earlier this year. Rocket Lab agreed to pay $54 per Iridium share in a mix of cash and stock, valuing the satellite operator at approximately $8 billion. To fund the cash portion, Rocket Lab secured a $3.6 billion bridge loan with a 364-day maturity. The target closing date is mid-2027, but the equity component — with an exchange ratio range of $67.50 to $112.50 — has fueled fears of shareholder dilution. Insider sales in recent weeks have only added to the unease.

Despite the sell-off, the underlying business continues to gain altitude. Rocket Lab reported first-quarter 2026 revenue of $200.35 million, a 63.5% jump from the prior year. The net loss per share narrowed to $0.07, while the backlog swelled to $2.2 billion, anchored by contracts from NASA, the U.S. Space Force, and commercial customers. On a trailing twelve-month basis, Simply Wall St estimates total revenue at $679.6 million, split between $452.5 million from Space Systems and $227.1 million from Launch. The analysis firm recently flagged Rocket Lab as one of three undervalued cash-flow stocks for retail investors, alongside TTM Technologies and United States Antimony.

The analyst community remains overwhelmingly bullish. Of the 16 analysts covering Rocket Lab, 81% rate it a Buy or Strong Buy; none recommend selling. The consensus price target of roughly $117 implies a 61% to 73% upside depending on the reference price used. That optimism stands in stark contrast to the Polymarket prediction platform, where participants assign an 88% probability that the stock will hit $64 and a 64.5% chance it will fall to $60. Only 5.2% see a recovery to $108. Historical accuracy for such Polymarket predictions sits at just 28.6%, but the bearish sentiment is unmistakable.

The next major inflection point will be the second-quarter 2026 earnings release, followed by an updated timeline for the Neutron rocket's maiden flight, currently planned for the fourth quarter. With the stock trading at roughly half its 52-week high of €133.80 and a wide buffer above the year's low of €32.60, the coming weeks will test whether the recent rout is a buying opportunity or the beginning of a deeper reassessment of Rocket Lab's growth narrative.